Eva Miquel
Barcelona, CT 08830, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.
Journal: Journal of atherosclerosis and thrombosis
Published: March 08, 2019
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
Journal: European archives of psychiatry and clinical neuroscience
Published: February 18, 2019
Design and Validation of an Instrument To Measure a Minor's Maturity When Faced with Health Decisions.
Journal: Journal of bioethical inquiry
Published: May 11, 2018
Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: March 16, 2016
Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
Journal: Schizophrenia bulletin
Published: November 23, 2015
The effect of raloxifene on symptoms and cognitive functioning in a postmenopausal schizophrenia patient: a case report.
Journal: Archives of women's mental health
Published: August 11, 2014
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: August 09, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026